About NGFI-A-binding protein 2
NGFI-A-binding protein 2 (NAB2) is a protein
from Homo sapiens identified by UniProt accession
Q15742, 525 residues long.
MolForge cross-references it against 0 known binders and
175 disease associations.
Target properties
| Protein name | NGFI-A-binding protein 2 |
| UniProt accession | Q15742 |
| Gene | NAB2 |
| Organism | Homo sapiens |
| Length | 525 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (175)
Diseases linked to this target (Open Targets).
- solitary fibrous tumor · score 0.38
- hemangiopericytoma · score 0.37
- meninges hemangiopericytoma · score 0.37
- T-Cell Prolymphocytic Leukemia · score 0.37
- meningioma · score 0.37
- Transitional Meningioma · score 0.37
- thyroid neoplasm · score 0.37
- Dedifferentiated Solitary Fibrous Tumor · score 0.37
- pleural solitary fibrous tumor · score 0.37
- insomnia measurement · score 0.30
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q15742-F1 | alphafold | PREDICTED | 62.47 | — |
Amino-acid sequence (525 residues)
MHRAPSPTAE QPPGGGDSAR RTLQPRLKPS ARAMALPRTL GELQLYRVLQ RANLLSYYET FIQQGGDDVQ QLCEAGEEEF LEIMALVGMA TKPLHVRRLQ KALREWATNP GLFSQPVPAV PVSSIPLFKI SETAGTRKGS MSNGHGSPGE KAGSARSFSP KSPLELGEKL SPLPGGPGAG DPRIWPGRST PESDVGAGGE EEAGSPPFSP PAGGGVPEGT GAGGLAAGGT GGGPDRLEPE MVRMVVESVE RIFRSFPRGD AGEVTSLLKL NKKLARSVGH IFEMDDNDSQ KEEEIRKYSI IYGRFDSKRR EGKQLSLHEL TINEAAAQFC MRDNTLLLRR VELFSLSRQV ARESTYLSSL KGSRLHPEEL GGPPLKKLKQ EVGEQSHPEI QQPPPGPESY VPPYRPSLEE DSASLSGESL DGHLQAVGSC PRLTPPPADL PLALPAHGLW SRHILQQTLM DEGLRLARLV SHDRVGRLSP CVPAKPPLAE FEEGLLDRCP APGPHPALVE GRRSSVKVEA EASRQ
Explore NGFI-A-binding protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets